Volume Alert - CFN 58.25 Carefusion Corp $CFN Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - CFN 58.25 Carefusion Corp $CFN Hit a high today of 58.28 Closing the day 10:30 at 58.25 +0.51 +0.88% With a day low of 57.68 and a total volume of 1,342,175.

CFN Recent Posts: http://investorshangout.com/Carefusion-Corp-CFN-50491/

CFN Carefusion Corp Recent Headline News

Becton Dickinson And CareFusion Announce Expiration Of HSR Act Waiting Period In Proposed Transaction
PR Newswire - Thu Nov 20, 8:05AM CST
Becton, Dickinson and Company (NYSE: BDX) ("BD" and CareFusion Corporation (NYSE: CFN) ("CareFusion" today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act" , in connection with BD's proposed acquisition of CareFusion expired on November 19, 2014.
BDX: 130.10 (-0.01), CFN: 58.21 (+0.47)

Global Fetal and Neonatal Care Equipment Market 2015-2019: Key Vendors are CareFusion, Drager Medical, GE Healthcare and Phillips Healthcare
M2 - Thu Nov 20, 4:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkv8pr/global_fetal_and) has announced the addition of the "Global Fetal and Neonatal Care Equipment Market 2015-2019" report to their offering. One of the major trends emerging in this market is the increased popularity of fetal MRI, which provides multiplanar images that help in facilitating diagnosis of large or complex anomalies in the fetus. According to the report, one of the major factors driving the market is the increase in the number of preterm births across the world. Nearly 15 million preterm babies are born every year. Preterm infants face great risk from short and long-term complications and require warmth, breastfeeding support, and respiratory assistance. Further, the report states that one of the major challenges in the market is the increasing number of product recalls in the market. Product recalls hamper the adoption of the product and affect the brand image of the vendor. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Product Market Size and Forecast Market Size and Forecast Market Size and Forecast 09. Geographical Segmentation 10. Key Leading Countries 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - CareFusion - Dr?ger Medical - GE Healthcare - Phillips Healthcare - Analogic - Covidien - Fisher & Paykel Healthcare - Getinge - Ivy Biomedical Systems - Masimo - Natus Medical - Nonin Medical - OSI Systems - Smiths Medical - Spacelabs Healthcare - Utah Medical Products - Welch Allyn For more information visit http://www.researchandmarkets.com/research/wk..._fetal_and
BABY: 33.34 (+0.08), CFN: 58.21 (+0.47), OSIS: 68.60 (+0.65), UTMD: 58.00 (-0.30)

Uptrend Call Working As CareFusion Stock Rises 30.0% (CFN)
Comtex SmarTrend(R) - Wed Nov 19, 11:10AM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 3 months, CareFusion has returned 30.02% as of today's recent price of $57.73.
CFN: 58.21 (+0.47)

CareFusion Earnings In Retrospect: Up 0.2% in the Last 11 Days (CFN)
Comtex SmarTrend(R) - Mon Nov 17, 11:03AM CST
11 days ago, on November 6th, 2014, CareFusion (NYSE:CFN) reported its earnings. Analysts, on average, expected earnings of $0.49 per share on sales of $919.3 million. CareFusion actually reported earnings of $0.50 per share on sales of $922.0 million, beating EPS estimates by $0.01 and beating revenue estimates by $2.7 million. Since the company's report, shares of CareFusion have risen from $57.44 to $57.57, representing a gain of 0.2% in the past 11 days.
CFN: 58.21 (+0.47)

Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014
M2 - Thu Nov 13, 6:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/6jjwbm/asiapacific) has announced the addition of the "Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014" report to their offering. The market for patient monitoring includes multi-parameter vital sign monitors, wireless ambulatory telemetry monitors, electromyogram (EMG) devices and consumables, electroencephalogram (EEG) monitors, fetal and neonatal monitors and pulse oximetry monitors and sensors. Report Contents: - Identified Strategic Opportunities - Market Overview by Segment & Country - Trend Analysis by Segment & Country - Market Drivers & Limiters - Mergers & Acquisitions - Competitive Analysis Key Highlights: - Includes additional information on reimbursement changes - Brazil report includes a section in appendix on public vs. private market pricing - Descriptive and qualitative information for the market drivers and limiters for each segment - New large segment - Processed EEG Depth of Anesthesia Monitoring - Extensive Qualitative insights into emerging trends and consumer retail sub-markets Key Topics Covered: 1. Executive Summary 2. Research Methodology 3. Asia-Pacific Patient Monitoring Equipment Market Overview 4. Country Profiles 5. Multi-Parameter Vital Sign Monitoring Market 6. Wireless Ambulatory Telemetry Monitor Market 7. Electromyogram Monitoring And Diagnostic Market 8. Electroencephalogram Monitoring And Diagnostic Market 9. Fetal And Neonatal Monitoring Market 10. Pulse Oximeter Market 11. Abbreviations Companies Mentioned - ArjoHuntleigh - Beijing Choice - Bionet - Cardiac Science - CareFusion - Compumedics - Covidien - Draeger Medical - Edan - Fukuda Denshi - GE Healthcare - Grass Technologies - Masimo - Mediana - Mindray - Natus Medical - Nihon Kohden - Nonin - Omron Healthcare - Philips Healthcare - Smiths Medical - Spacelabs - Teijin Pharma - Welch Allyn For more information visit http://www.researchandmarkets.com/research/6j...siapacific
BABY: 33.34 (+0.08), CFN: 58.21 (+0.47)

CareFusion Shares Up 29.7% Since SmarTrend's Buy Recommendation (CFN)
Comtex SmarTrend(R) - Wed Nov 12, 9:50AM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 3 months, CareFusion has returned 29.71% as of today's recent price of $57.59.
CFN: 58.21 (+0.47)

CareFusion Q1 Earnings, Revenues Rise and Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:30AM CST
CareFusion Corporation (CFN) now expects adjusted earnings to increase in the range of $2.80-$2.95 per share, higher than the earlier band of $2.60-$2.75 per share.
BDX: 130.10 (-0.01), BCR: 166.54 (-0.13), BAX: 71.77 (-0.69), CFN: 58.21 (+0.47)

CareFusion beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:17PM CST

CFN: 58.21 (+0.47)

CareFusion Reports First Quarter Fiscal 2015 Results
PR Newswire - Thu Nov 06, 3:02PM CST
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended Sept. 30.
CFN: 58.21 (+0.47)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:35PM CST

BEBE: 2.54 (+0.02), ACET: 21.08 (+0.08), ANET: 75.40 (-1.60), FNGN: 32.29 (-0.08), CPST: 0.85 (+0.02), AUQ: 3.99 (+0.03), AMRN: 1.25 (unch), ED: 62.14 (-0.20), ENV: 52.01 (-0.57), FXCM: 15.96 (-0.18), BCEI: 36.92 (+1.12), GXP: 26.66 (+0.05), EAC: 11.00 (unch), DXCM: 50.99 (+0.51), CSC: 62.86 (+0.58), AEL: 26.99 (+0.10), HNSN: 0.80 (-0.03), CFN: 58.21 (+0.47), ANAC: 31.37 (+1.04), DAR: 18.98 (+0.08), GST: 4.06 (-0.01), ARC: 9.33 (-0.07), FIVN: 4.35 (-0.07), ELON: 1.84 (+0.01), FSLR: 49.48 (+0.66), EZPW: 10.79 (+0.11), ALIM: 5.47 (+0.02), FWM: 3.11 (+0.22), BRS: 70.37 (+0.87), ECOM: 17.73 (+0.40), FTEK: 4.10 (unch), CVT: 27.23 (+0.48), AL: 37.36 (-0.09), BBRG: 12.96 (+0.02), BPZ: 0.98 (+0.07), ECPG: 42.42 (-0.98), HTGC: 15.55 (-0.07), AIRM: 44.50 (+0.08), BNFT: 22.76 (+0.30), ENOC: 14.91 (+0.10), HPTX: 20.88 (+0.18), AGO: 24.98 (+0.28), FICO: 71.95 (+0.27), FF: 12.06 (-0.05), FI: 20.13 (+0.31), EVC: 5.59 (+0.12), EBS: 24.26 (+0.27), ABCO: 41.26 (-0.43), DIOD: 26.03 (+0.34), DIS: 88.98 (-0.84), EGOV: 17.85 (+0.45), APEI: 35.05 (-0.12), DVA: 75.05 (-0.07), CLVS: 50.12 (+1.84), HCI: 40.58 (+0.49), BRKR: 18.46 (+0.43), HGR: 20.40 (+0.39)

CareFusion Has Returned 29.7% Since SmarTrend Recommendation (CFN)
Comtex SmarTrend(R) - Wed Nov 05, 9:18AM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 3 months, CareFusion has returned 29.66% as of today's recent price of $57.57.
CFN: 58.21 (+0.47)

Will CVS Health (CVS) Keep its Earnings Streak Alive in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 2:30PM CST
CVS Health Corporation (CVS) is scheduled to report its third-quarter 2014 results before the opening bell on Nov 4.
AMSG: 50.56 (+0.68), CFN: 58.21 (+0.47), CVS: 89.40 (-0.19), HSIC: 131.14 (-0.96)

Clinical Trial Results, Product Approval Letter, Financial Results, and Upcoming Event - Research Reports on Receptos, Wright, United Therapeutics, Abbott and CareFusion
PR Newswire - Fri Oct 31, 7:40AM CDT
Today, Analysts Review released its research reports regarding Receptos Inc. (NASDAQ: RCPT), Wright Medical Group Inc. (NASDAQ: WMGI), United Therapeutics Corporation (NASDAQ: UTHR), Abbott Laboratories (NYSE: ABT) and CareFusion Corporation (NYSE: CFN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7594-100free.
ABT: 43.52 (+0.09), WMGI: 28.35 (-0.24), CFN: 58.21 (+0.47), UTHR: 129.48 (+1.48), RCPT: 115.99 (+8.04), WMGIZ: 4.35 (-0.01)

Morning Analysis on Health Care Equipment Stocks - Zimmer Holdings, Edwards Lifesciences, Varian Medical Systems, CareFusion, and Baxter Intl.
PR Newswire - Tue Oct 28, 7:35AM CDT
Investor-Edge has initiated coverage on the following equities: Zimmer Holdings Inc. (NYSE: ZMH), Edwards Lifesciences Corporation (NYSE: EW), Varian Medical Systems Inc. (NYSE: VAR), CareFusion Corporation (NYSE: CFN), and Baxter International Inc. (NYSE: BAX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, October 27, 2014, the NASDAQ Composite ended at 4,485.93, up 0.05%, the Dow Jones Industrial Average edged 0.07% higher to finish the day at 16,817.94, and the S&P 500 closed at 1,961.63, down 0.15%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 755.35, up 0.12%, with the index also advancing 5.54% in the previous three months. Register for your complimentary reports on these five stocks at:
ZMH: 110.29 (-0.26), VAR: 87.64 (-0.02), BAX: 71.77 (-0.69), CFN: 58.21 (+0.47), EW: 124.95 (-0.64)

Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 511.73 (-1.30), ELOS: 9.91 (+0.06), VRX: 142.13 (-0.34), ZLTQ: 28.59 (+0.47), VAR: 87.64 (-0.02), CFN: 58.21 (+0.47), STNR: 42.79 (+0.79)

SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of CareFusion Corporation -- CFN
GlobeNewswire - Wed Oct 22, 2:18PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the Delaware Court of Chancery on behalf of all common stockholders of CareFusion Corporation ("CareFusion" or the "Company" (NYSE:CFN) opposing the proposed acquisition of CareFusion by Becton, Dickinson and Company ("BD" .
CFN: 58.21 (+0.47)

Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion
PR Newswire - Tue Oct 21, 8:15AM CDT
Today, Analysts Review released its research reports regarding Simon Property Group Inc. (NYSE: SPG), The Regions Financial Corporation (NYSE: RF), American Capital Agency Corp. (NASDAQ: AGNC), CareFusion Corporation (NYSE: CFN) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7336-100free.
RF: 9.96 (-0.11), SPG: 178.34 (+1.97), CFN: 58.21 (+0.47), ALXN: 192.17 (+0.21), AGNC: 23.16 (+0.04)

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of CareFusion Corporation of Class Action Against the Board of Directors of the Company Challenging the Fairness of the Sale of the Company to Becton Dickinson & Co. -- CFN
GlobeNewswire - Mon Oct 20, 9:28AM CDT
Levi & Korsinsky notifies investors of CareFusion Corporation ("CareFusion" or "the Company" (NYSE:CFN) of claims of breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Becton Dickinson & Co. ("Becton Dickinson" . A complaint was filed in Delaware state court.
BDX: 130.10 (-0.01), CFN: 58.21 (+0.47)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 173

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 50

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
Villa Group’s Punta Mita Bet Adds 305 Luxury Resort Keys

Updated Category News Views 74

A 12.6-acre slice of Riviera Nayarit coastline is about to get a very expensive makeover, assuming The Villa Group can turn a handsome plan into a functioning resort without the usual development headaches. The company says it has acquired a beachfront parcel in Litibú and intends to build Villa La Valencia Punta Mita, a 305-accommodation luxury property aimed squarely...

Continue Reading
Esquire Spotlight Puts Trauma Cleanup Work in Focus

Updated Category News Views 21

A national magazine profile is an odd milestone for a business built around other people’s worst days. David Lesaffre, co-owner and operator of T.A.C.T. 48, T.A.C.T. AZ, and T.A.C.T. Fort Worth, has been featured by Esquire in a piece called “The Trauma Cleaners.” The attention is deserved, frankly, because biohazard remediation is one of those necessary services...

Continue Reading
TGHL Eyes U.S. Battery Shift Through EnChem Merger

Updated Category News Views 43

A Policy Squeeze Is Rewriting the Battery Map Battery supply chains are getting shoved through a narrower gate, and that is exactly why this proposed deal deserves a hard look. The GrowHub Limited wants to acquire EnChem America, a Georgia-based lithium-ion battery electrolyte producer, and the timing is plainly built around Washington's push to reduce reliance on...

Continue Reading
Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 229

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
Lotte's Songdo Plant 1 Puts 120,000 Liters on Deck

Updated Category News Views 44

A 120,000-liter biomanufacturing plant is not a ribbon-cutting trinket; it is a serious industrial bet that has to earn its keep one qualified batch at a time. LOTTE Biologics has completed Plant 1 at its Songdo Bio Campus in Incheon, South Korea, giving the company a sizable new production base as it tries to become a more consequential player in the global CDMO...

Continue Reading
NextPatient’s KLAS Marks Signal Specialty Workflow Fit

Updated Category News Views 35

A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 105

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Seeking Alpha Premium Review: Data Meets Human Judgment

Updated Category News Views 102

A spreadsheet can spot a cracked windshield, but it cannot tell you where the truck is headed. That is the useful, slightly irritating truth behind Seeking Alpha Premium’s 2026 pitch: it puts an enormous amount of stock-research machinery in one place, yet the investor still has to do the driving. Software Experts has highlighted the service in its review of...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Crypto Volatility and the REX Osprey XRP ETF

Updated Category News Views 134

Cryptocurrency Market Overview and Recent Trends Up until October, the cryptocurrency market was experiencing significant growth, with a total capitalization reaching approximately $4.28 trillion. This surge was driven by abundant liquidity and a heightened risk appetite among investors. However, the capital markets can be unpredictable, leading to a swift and adverse...

Continue Reading
Intelligent Bio Inks Global Deal to Expand Drug Testing Solutions

Updated Category News Views 126

Intelligent Bio Solutions Launches Global Distribution Pact Intelligent Bio Solutions Inc. (NASDAQ: INBS) has recently announced an exciting global distribution partnership with SMARTOX. This collaboration aims to introduce their innovative SmarTest Patch, a cutting-edge product designed for drug detection, to international markets beyond the U.S. and Canada, marking a...

Continue Reading
Discover the Long-Term Growth of American Financial Group AFG Stock

Updated Category News Views 148

The Remarkable Journey of American Financial Group (AFG) American Financial Group (AFG) has significantly outperformed the market over the past twenty years, showing an annualized return of 9.37%, which surpasses the market by 1.29%. With a market capitalization standing at an impressive $10.39 billion, AFG is a noteworthy player in the financial sector. Investment...

Continue Reading
Current Sentiment Analysis: Canaan Inc's Short Interest Insights

Updated Category News Views 352

Canaan Inc's Current Short Interest Overview Canaan Inc (NYSE: CAN) is witnessing changes in its stock sentiment, particularly regarding its short interest. Recent reports indicate that the short interest, expressed as a percentage of the float, has dropped by 8.14%. Currently, 36.17 million shares are sold short, representing 8.58% of the total shares available for...

Continue Reading
CalExitNow Push for CA GOP Ban & Sovereignty Talks

Updated Category News Views 296

California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...

Continue Reading